期刊文献+

MGMT及表皮生长因子受体在喉鳞癌中的表达及对预后的影响 被引量:1

Expression of MGMT and epidermal growth factor receptor in laryngeal squamous cell carcinoma and its effect on prognosis
下载PDF
导出
摘要 目的研究探讨喉鳞状细胞癌中MGMT及表皮生长因子受体蛋白的表达与临床资料间的关系及其对治疗预后的影响。方法标本均选取2016年1月~2017年6月于我院耳鼻喉科手术治疗的93例喉鳞状细胞癌(laryngeal squamous cell carcinoma,LSCC)患者的石蜡切片,经病理学确诊为LSCC标本。选取20例健康喉黏膜组织标本作为对照组。采用免疫组化染色法检测O6-甲基鸟嘌呤-DNA-甲基转移酶(O6-methylguanine-DNA-methyltransferase,MGMT)与表皮生长因子受体蛋白(epidermal growth factor receptor,EGFR)的表达水平。评价肿瘤组与对照组之间MGMT、表皮生长因子受体蛋白(EGFR)的表达差异;评价肿瘤组中MGMT、EGFR的表达水平与其各项临床资料间的关系;评价肿瘤组中MGMT与EGFR表达之间的关系。结果肿瘤组与对照组之间MGMT、EGFR的表达比较,差异具有统计学意义;肿瘤组中MGMT、EGFR的表达水平与病理分期和分化程度呈正相关关系;肿瘤组中MGMT与EGFR表达呈正相关。结论本次研究证明喉鳞状细胞癌中MGMT、EGFR的表达与病理分期和分化程度呈正相关,MGMT、EGFR的高表达往往意味着肿瘤预后不良且比通过疾病分期预后更为准确。MGMT、EGFR的表达作为LSCC的生物指标值得临床推广。 Objective To investigate the relationship between the expression of MGMT and epidermal growth factor receptor (EGFR) and clinical data in laryngeal squamous cell carcinoma and its effect on the prognosis of treatment. Methods Paraffin section of 93 cases of Laryngeal squamous cell carcinoma(LSCC) who were treated in the Department of Otolaryngology in our hospital from January 2016 to June 2017 were selected. All the specimens were pathologically confirmed as LSCC specimens. 20 specimen of healthy laryngeal mucosa were selected as control group. The expression of O6-methylguanine-DNA-methyhransferase (MGMT) and epidermal growth factor receptor(EGFR) was detected by immunohistoehemieal staining. The differences in expression of MGMT and epidermal growth factor reeeptor(EGFR) protein between tumor group and control group were evaluated. The relationship between MGMT, EGFR expression levels and their clinical data in tumor groups was evaluated. The relationship between MGMT and EGFR expression in tumor groups was evaluated. Results There were significant differences in the expression of MGMT and EGFR between the tumor group and the control group (P〈0.05). The expression levels of MGMT and EGFR in the tumor group were positively correlated with pathological stage and differentiation (P〈0.05). There was a positive correlation between MGMT and EGFR expression in the tumor group(P〈0.05). Conclusion This study demonstrates that the expression of MGMT and EGFR is positively correlated to the pathological stage, differentiation in laryngeal squamous cell carcinoma. The high expression of MGMT and EGFR often means that the prognosis of the tumor is poor and it is more accurate in prognosis than the staging of the disease. The expression of MGMT and EGFR is worthy of clinical promotion as a biological indicator of LSCC.
作者 宋晓晓 林刃舆 SONG Xiaoxiao;LIN Renyu(Department of Otolaryngology,the First Affiliated Hospital of Wenzhou Medical University,Wenzhou 325000,China)
出处 《中国现代医生》 2018年第24期60-63,74,共5页 China Modern Doctor
基金 浙江省自然科学基金(LY14H130003)
关键词 喉鳞状细胞癌 表皮生长因子 MGMT 预后 免疫组化染色 Laryngeal squamous cell carcinoma Epidermal growth factor MGMT Prognosis Immunohistochemical staining
  • 相关文献

参考文献8

二级参考文献77

  • 1廖小金.表皮生长因子结构和生物学效应[J].海峡药学,2006,18(5):14-17. 被引量:21
  • 2韩宇,徐建明,段海清,宋三泰,刘晓晴,张扬,张京生.EGFR基因突变与吉非替尼治疗晚期非小细胞肺癌的疗效和预后的关系[J].中华肿瘤杂志,2007,29(4):278-283. 被引量:25
  • 3Bublil EM, Yarden Y, The EGF receptor family : spearheading a merger of signaling and therapeutics [ J ]. Curr Opin Cell Biol, 2007, 19 ( 2 ) : 124-134. DOI : 10.1016/j.ceb.2007.02.008.
  • 4Bethune G, Bethune D, Ridgway N, et al. Epidermal growth factor receptor ( EGFR ) in lung cancer: an overview and update [ J ]. J Thorac Dis, 2010, 2 ( 1 ) : 48-51. DOI:10.3978/j.issn.2072- 1439.2010.02.01.017.
  • 5Lee HI, Xu X, Choe G, et al. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas : Comparison of four commercially available antibodies by immunohistochemistry and fluorescence in situ hybridization study [J]. Lung Cancer, 2010, 68(3): 375-382. DOI:10.1016/j. lungean.2009.07.014.
  • 6Minami T, Kijima T, Satoshi K, et al. Overcoming ehemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody- dependent cell-mediated cytotoxicity and antiangiogenesis [ J ]. Sci Rep, 2013 10.1038/srep02669. VEGF-targeted 2669. DOI :.
  • 7Onn A, Correa AM, Gilcrease M, et al. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer [ J ]. Chn Cancer Res, 2004, 10 ( 1 pt 1 ) : 136-143. DOI: 10.1158/1078-0432.CCR-0373-3.
  • 8Cheng CM, Tsuneyama K, Matsui K, et al. Cytoplasmic expression of c-erbB2 in non-small cell lung cancers [ J ]. Virchows Arch, 2005, 446 ( 6 ) : 596-603. DOh 10.1007/s00428-005-1258-7.
  • 9Amin DN, Campbell MR, Moasser MM. The role of HER3,the unpretentious member of the HER family, in cancer biology and cancer therapeutics [ J ]. Semin Cell Dev Biol, 2010, 21 ( 9 ) : 944- 950. DOI : 10.1016/j.semcdb.2010.08.007.
  • 10Koutsopoulos AV, Mavroudis D, Damhaki KI, et al. Simultaneous expression ofc-erbB-1, c-erbB-2, c-erbB-3 and c-erbB-4 receptors in non-small-cell lung carcinomas: correlation with clinical outcome [J]. Lung Cancer, 2007, 57 (2): 193-200. DOI:10.1016/j. lungcan.2007.03.009.

共引文献38

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部